Japanese Government Accelerates Hemispherx Biopharma's Ampligen(r) Research Programs for Influenza Protection
GlobeNewswire News ReleasesPublished: 04/27/09 11:18 AM EDTReleased By:
Hemispherx Biopharma, Inc.
NewsvineFlu Virus Mutations May Limit Tamiflu Usefulness
PHILADELPHIA, April 27...